Evaluating GxP software is one of those tasks where the obvious approach — review vendor websites, request demos, compare feature lists — misses most of what actually determines whether a platform will work for your team. Feature lists tell you what the software can do in theory. What matters is what it does in your specific environment, with your specific team size, your specific regulatory obligations, and your specific validation workload. Here is the evaluation framework that quality leaders who have been through this process multiple times actually use.
The weighted scoring framework
Before you see a single demo, define your criteria and weight them. Not every criterion matters equally for every team. Here is a starting framework that you should adjust for your situation:
| Criterion | Weight | What to assess |
|---|---|---|
| Time to first value | 25% | How quickly can your team complete a real validation project? Not "implementation timeline" — actual value delivery. |
| Deliverable quality | 20% | Are the validation deliverables inspection-ready? Would your QA director sign them? |
| Risk-based testing / CSA support | 15% | Does the platform score risk at the requirement level and calibrate testing accordingly? |
| Regulatory compliance | 15% | Part 11, Annex 11/22, audit trails, e-signatures — built in, not bolted on? |
| Total cost of ownership | 15% | License + implementation + admin + validation of the tool + ongoing maintenance over 3 years |
| Team fit | 10% | Can your actual team (not an idealised team) use this effectively? |
The demo script that reveals what marketing hides
Do not let the vendor drive the demo. Bring your own scenario — a real system that your team needs to validate — and ask the vendor to walk through it. Here is the script:
- "Start a validation project for our LIMS from scratch. I want to see the intake." Watch how much information you need to provide versus how much the platform infers or guides you through. A good platform should guide the intake; a great platform should draft the initial GAMP classification and risk assessment from what you provide.
- "Show me the draft risk assessment." Is it per-requirement risk scoring under CSA, or a single risk assessment for the whole system? Per-requirement is what modern validation requires.
- "Now change one requirement and show me what updates." Does the traceability matrix update automatically? Do affected test cases flag for review? Or does everything stay static until someone manually updates it?
- "Show me the audit trail for what we just did." Every action should be captured — who, what, when, before/after values. If the vendor says "we can configure audit trail settings," that means it is not on by default, which is a red flag.
- "Show me a finished, signed validation package." Not a sample or a template — an actual deliverable with electronic signatures. If the vendor cannot show you signed output, the Part 11 compliance is incomplete.
Reference check questions that actually matter
- "How long from contract signature to first completed validation project?" Not "implementation" — first real value. If the answer is more than three months, ask why.
- "What did you wish you had known before buying?" Open-ended, gets honest responses.
- "Has the platform survived a regulatory inspection?" Has an inspector actually reviewed validation evidence produced by this platform? What was the outcome?
- "How many people on your team actually use it regularly?" If the answer is "one or two," the platform is too complex for general use. A good validation platform should be used by the whole validation team, not just a specialist.
- "What do you spend annually beyond the license fee?" Implementation, consultants, admin time, training — the total cost picture.
Red flags in the evaluation process
- The vendor cannot show real output. If every demo uses mockups, sample data, and "this is what it would look like," the platform may not actually produce what they are showing you.
- Implementation requires "certified consultants." If you cannot implement the software yourself or with light vendor support, the platform is too complex for your team size.
- The AI features are "coming soon." AI-washing is rampant in the GxP software market. If the vendor talks about AI capabilities that are on the roadmap rather than in production, score them on what exists today.
- The pricing is opaque. If getting a price quote requires multiple calls, a "discovery session," and a custom proposal, the pricing is designed to be as high as each customer will tolerate. Transparent pricing is a signal of confidence.
- No references at your company size. A platform that works for Pfizer may not work for a 100-person biotech, and vice versa. Ask for references at companies similar to yours in size and complexity.
Making the final decision
After evaluating three to four platforms, narrow to two finalists and run a parallel pilot. Give each finalist the same real validation project — a system that actually needs validation — and compare the results side by side. Not features, not promises, not demo impressions — actual output from actual use. The platform that produces better validation evidence, faster, with less effort from your team is the right choice. Everything else is noise. book a demo if you want GxP Copilot to be one of your finalists — we will run the pilot on your actual system, not a demo scenario.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.